AFT Pharmaceuticals announced the appointment of Andrew Lane as an independent non-executive director. The appointment fills the vacancy left by Jon Lamb who retires from the board on 28 September 2023 following his 11-year tenure. The board has determined that Andrew Lane is an Independent Director (within the meaning of the NZX Listing Rules).